2024 Q4 Form 10-Q Financial Statement

#000101738624000272 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $81.64K
YoY Change 13.95%
Operating Profit -$81.64K
YoY Change 19.38%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$2.061K
YoY Change -642.37%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$83.70K
YoY Change 23.07%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 78.09M shares 78.08M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $10.23K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $11.35K
YoY Change -53.0%
LONG-TERM ASSETS
Property, Plant & Equipment $2.749K
YoY Change -26.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.749K
YoY Change -26.34%
TOTAL ASSETS
Total Short-Term Assets $11.35K
Total Long-Term Assets $2.749K
Total Assets $14.10K
YoY Change -49.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.187K
YoY Change -73.25%
Accrued Expenses $14.81K
YoY Change 36.26%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $410.8K
YoY Change 296.84%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $410.8K
Total Long-Term Liabilities
Total Liabilities $410.8K
YoY Change 296.84%
SHAREHOLDERS EQUITY
Retained Earnings -$1.564M
YoY Change 27.81%
Common Stock $78.08K
YoY Change -2.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$396.7K
YoY Change
Total Liabilities & Shareholders Equity $14.10K
YoY Change -49.44%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$83.70K
YoY Change 23.07%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address Address Line1
EntityAddressAddressLine1
2355 Highway 36 West
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
dei City Area Code
CityAreaCode
(651)
dei Local Phone Number
LocalPhoneNumber
317-8990
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3486 usd
CY2023Q4 scth Accounts Payable Related Party
AccountsPayableRelatedParty
40000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3400 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
3 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
79863 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1076391 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1305128 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-148871 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24217 usd
CY2023Q3 us-gaap Revenues
Revenues
4450 usd
us-gaap Revenues
Revenues
14235 usd
us-gaap Gross Profit
GrossProfit
10814 usd
us-gaap Gross Profit
GrossProfit
30839 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
69906 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
265868 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
311183 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
71646 usd
us-gaap Operating Expenses
OperatingExpenses
265868 usd
us-gaap Operating Expenses
OperatingExpenses
319684 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-68390 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-255054 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-288845 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
378 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3838 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1788 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-68012 usd
us-gaap Net Income Loss
NetIncomeLoss
-258892 usd
us-gaap Net Income Loss
NetIncomeLoss
-287057 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001703157
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2024Q3 us-gaap Revenues
Revenues
usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 scth Share Exchange Unrelated
ShareExchangeUnrelated
usd
CY2023Q2 scth Share Exchange Unrelated
ShareExchangeUnrelated
usd
CY2023Q3 scth Share Exchange Unrelated
ShareExchangeUnrelated
usd
scth Imputed Interest
ImputedInterest
usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
usd
us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Interest Paid
InterestPaid
usd
scth Stock Issued2
StockIssued2
usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55927
dei Entity Registrant Name
EntityRegistrantName
SecureTech Innovations, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-0972782
dei Entity Address City Or Town
EntityAddressCityOrTown
Roseville
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55113
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78086881 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5987 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
10234 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
13656 usd
CY2024Q3 us-gaap Deposit Assets
DepositAssets
1114 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
1088 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
11348 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
20731 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2749 usd
CY2024Q3 us-gaap Assets
Assets
14097 usd
CY2023Q4 us-gaap Assets
Assets
24217 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9187 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5879 usd
CY2024Q3 scth Accounts Payable Related Party
AccountsPayableRelatedParty
85978 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
269918 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
112328 usd
CY2024Q3 us-gaap Bank Overdrafts
BankOverdrafts
182 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14807 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14564 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
29611 usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1115 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
317 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
410797 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
173088 usd
CY2024Q3 us-gaap Liabilities
Liabilities
410797 usd
CY2023Q4 us-gaap Liabilities
Liabilities
173088 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3400 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3200 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3200 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
3 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78076881 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78076881 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79862655 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79862655 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
78077 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1089240 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1564020 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-396700 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14097 usd
us-gaap Revenues
Revenues
42050 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1194 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3421 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11211 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
3256 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
81642 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1740 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8501 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
81642 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-81642 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2061 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-83703 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
78076881 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
80615730 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
78170883 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
98574867 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-148871 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-81481 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
230352 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-93708 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
314060 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-83703 usd
CY2024Q3 scth Imputed Interest
ImputedInterest
1063 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-396700 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
175420 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-113959 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
81461 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-105086 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23625 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-68012 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
75637 usd
us-gaap Net Income Loss
NetIncomeLoss
-258892 usd
us-gaap Net Income Loss
NetIncomeLoss
-287057 usd
us-gaap Depreciation
Depreciation
737 usd
us-gaap Depreciation
Depreciation
738 usd
scth Imputed Interest
ImputedInterest
1063 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3422 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12342 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3308 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
32779 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
45978 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
242 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2327 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
157590 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
45703 usd
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-26 usd
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
29500 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
798 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
1770 usd
us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
182 usd
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-45598 usd
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-166552 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
36000 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
29611 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39611 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5987 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-130552 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5987 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138318 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7766 usd
us-gaap Interest Paid
InterestPaid
3061 usd
scth Stock Issued2
StockIssued2
5000 usd
us-gaap Stock Issued1
StockIssued1
1796 usd
us-gaap Stock Issued1
StockIssued1
27000 usd
us-gaap Reclassifications
Reclassifications
<p id="xdx_84D_eus-gaap--Reclassifications_zUQaVggleaWe" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Reclassifications</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">For comparability, prior-year balances were reclassified to conform with current-year presentations, such as accounts payable—related party, which were previously included in accounts payable in 2023.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zyy9Apa3y4gl" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates that have been made using careful judgment. Actual results may vary from these estimates.</p> <hr style="border-width: 0; margin: 14pt 0 0; height: 0; width: 0"/> <hr style="border-width: 0; margin: 8pt 0; page-break-after: always; height: 3pt; background-color: #909090"/> <p style="font: 10pt Times New Roman; margin: 0"> </p> <p style="font: 10pt Times New Roman; margin: 0"> </p> <hr style="border-width: 0; margin: 14pt 0 0; height: 0; width: 0"/>
us-gaap Depreciation
Depreciation
737 usd
us-gaap Depreciation
Depreciation
738 usd
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
4916 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
4916 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2167 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1430 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2749 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3486 usd
us-gaap Fiscal Period
FiscalPeriod
<p id="xdx_846_eus-gaap--FiscalPeriod_zT9ERqd7uMX" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Fiscal Year</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The Company elected December 31st for its fiscal year end.</p> <p style="font: 10pt Times New Roman; margin: 0"> </p>
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1564020 usd
CY2024Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1913 usd
CY2023Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1925 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8321 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11731 usd
CY2024Q3 us-gaap Inventory Gross
InventoryGross
10234 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
13656 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
10234 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
13656 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
250000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3400 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
200
us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
1,795,774
CY2024Q3 us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
700
CY2024Q3 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
7,000,000
CY2024Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.00
CY2023Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.75
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78076881 shares
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
80500000 shares
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
13704226 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
26795774 shares
CY2023Q3 scth Convertible Preferred Stock Shares Issued Upon Conversion Qtr
ConvertiblePreferredStockSharesIssuedUponConversionQtr
200 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
2000000 shares
CY2023Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
2700 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
27000000 shares
CY2024Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
200 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1795774 shares
CY2024Q3 scth Accrued Payroll
AccruedPayroll
260738 usd
CY2023Q4 scth Accrued Payroll
AccruedPayroll
58500 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4590 usd
CY2024 us-gaap Payments For Royalties
PaymentsForRoyalties
1 usd
CY2023 scth Patent Royalty Contribution
PatentRoyaltyContribution
2929 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
29611 usd
scth Imputed Interest
ImputedInterest
1063 usd
CY2024Q3 scth Accounts Payable Related Party
AccountsPayableRelatedParty
85978 usd
CY2023Q4 scth Accounts Payable Related Party
AccountsPayableRelatedParty
40000 usd
CY2024Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10000 usd
CY2024Q4 us-gaap Notes Payable Current
NotesPayableCurrent
39611 usd
CY2024Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.50
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78086881 shares
CY2024Q4 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
50000 usd
CY2024Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
50000 usd
CY2024Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
50000 usd
CY2024Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
100000000 shares
CY2024Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
10000 shares
CY2024Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
13400 shares

Files In Submission

Name View Source Status
0001017386-24-000272-index-headers.html Edgar Link pending
0001017386-24-000272-index.html Edgar Link pending
0001017386-24-000272.txt Edgar Link pending
0001017386-24-000272-xbrl.zip Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gen19stsec10q9302410q9302_1.jpg Edgar Link pending
gen19stsec10q9302410q9302_2.jpg Edgar Link pending
gen19stsec10q9302410q9302_3.jpg Edgar Link pending
gen19stsec10q9302410q9302_4.jpg Edgar Link pending
gen19stsec10q9302410q9302_5.jpg Edgar Link pending
gen19stsec10q9302410q9302_6.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scth-20240930.xsd Edgar Link pending
scth_form10q093020224.htm Edgar Link pending
scth-20240930_lab.xml Edgar Link unprocessable
scth-20240930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending
scth_form10q093020224_htm.xml Edgar Link completed
scth-20240930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
scth-20240930_def.xml Edgar Link unprocessable